Nov 10 (Reuters) - Nuvo Pharmaceuticals Inc NRI.TO :
* Nuvo Pharmaceuticals Inc - net income from continuing operations for Q3 of 2016 was $1.3 million compared to $2.1 million
* Nuvo anticipates signing licensing agreements of pennsaid 2pct covering multiple countries beginning in 2017
* Nuvo Pharmaceuticals announces 2016 third quarter results
* Q3 revenue C$5.5 million Source text for Eikon: ID:nCNWfsp0Ma Further company coverage: NRI.TO